- Home
- NPV vs STIM Comparison
NPV vs STIM Comparison
Compare NPV & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPV
- STIM
- Stock Information
- Founded
- NPV 1993
- STIM 2003
- Country
- NPV United States
- STIM United States
- Employees
- NPV N/A
- STIM N/A
- Industry
- NPV Investment Managers
- STIM Medical/Dental Instruments
- Sector
- NPV Finance
- STIM Health Care
- Exchange
- NPV Nasdaq
- STIM Nasdaq
- Market Cap
- NPV 199.1M
- STIM 221.8M
- IPO Year
- NPV N/A
- STIM 2018
- Fundamental
- Price
- NPV $11.07
- STIM $3.87
- Analyst Decision
- NPV
- STIM Buy
- Analyst Count
- NPV 0
- STIM 4
- Target Price
- NPV N/A
- STIM $5.67
- AVG Volume (30 Days)
- NPV 38.9K
- STIM 1.2M
- Earning Date
- NPV 01-01-0001
- STIM 08-05-2025
- Dividend Yield
- NPV 3.90%
- STIM N/A
- EPS Growth
- NPV N/A
- STIM N/A
- EPS
- NPV N/A
- STIM N/A
- Revenue
- NPV N/A
- STIM $111,106,000.00
- Revenue This Year
- NPV N/A
- STIM $105.22
- Revenue Next Year
- NPV N/A
- STIM $11.89
- P/E Ratio
- NPV N/A
- STIM N/A
- Revenue Growth
- NPV N/A
- STIM 54.17
- 52 Week Low
- NPV $8.92
- STIM $0.52
- 52 Week High
- NPV $11.55
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- NPV 52.64
- STIM 43.61
- Support Level
- NPV $10.95
- STIM $3.79
- Resistance Level
- NPV $11.06
- STIM $4.85
- Average True Range (ATR)
- NPV 0.07
- STIM 0.36
- MACD
- NPV 0.02
- STIM -0.08
- Stochastic Oscillator
- NPV 84.78
- STIM 19.01
About NPV Nuveen Virginia Quality Municipal Income Fund
Nuveen Virginia Quality Municipal Income Fund is a diversified closed-end management investment company. The fund seeks to provide current income exempt from both regular federal and designated state income taxes. The fund invests in a portfolio of municipal obligations issued by state and local government authorities.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.